Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida — Clinical Trial Site

155 Registered trials

63 Currently recruiting

Organisation

Hospital Universitari Arnau De Vilanova De La Gerencia Territorial De Lleida

Location

Lleida, Spain

Identifier

ORG-100032779

Address

Avinguda De L'alcalde Rovira Roure 80, 25196, Spain

Departments

-
#034002 Oncología Médica
#2320: servicio de neurología
#2505: Servicio de oncología médica
1320: Hematologia
3401-Gastroenterología
7201: Neurology
Anaesthesiology
Anaesthesiology and Pain Management
Anestesiology
Cardiología
Cardiology
Cardiology Service
cirugia
Departamento de Neurología
Endocrinology
Endocrinology and metabolism
Endocrinology and nutrition
ES006:Pediatría
Gastroenterology
Haematology
Hematología
Hematology
Hematology and Oncology
Institut de Recerca Biomedica Lleida (IRB Lleida).
Intensive Care
Intensive Medicine
Internal Medicine
MEDICAL ONCOLOGY
Medicina Interna
NA
Nefrología
Neonatology
Nephrology
Neprology
Neumología
Neurología
Neurology
Not applicable
Obstetrician and Gynecologist
Oncolgy
Oncología
Oncology
Oncology department
Oncology Service
Pulmonology
Respiratory medicine
Servicio de Endocrinología
Servicio de Nefrologia
Servicio de Neurología
Servicio de Oncologia
Servicio de Oncología Médica
Surgery
Thoracic Oncology
Traumatology

Clinical trials at this site (155)

Search interface

A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants with Early Breast Cancer (EMBER-4) Recruiting

2022-501007-28-00 Breast Neoplasms 5 2023-04-18
A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K in… Recruiting

2022-501152-28-00 Breast Cancer 4 2022-12-21
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Secondary progressive multiple sclerosis 5 2026-04-21
Exploring the anti-aging effects of Metformin in COPD Recruiting

2025-520972-24-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2026-04-08
A Study of Evorpacept (ALX148) in Patients with Metastatic HER2-Positive Breast Cancer Recruiting

2025-522012-16-00 Breast Cancer 4 2026-03-13
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer (OPERA-02) Recruiting

2025-522873-12-00 ER+, HER2- Advanced Breast Cancer 5 2026-02-24
Patient-Centered Study of T-DXd in Metastatic HER2-Positive Breast Cancer with Real-Life Side Effect Management Recruiting

2025-521805-41-00 Patients with HER2-positive, locally advanced or metast 5 2026-02-18
A study to compare different doses of RO7268489 with a placebo (as add-on therapy to ocrelizumab) in people with multiple sclerosis that has… Recruiting

2025-521636-10-00 Progressive Forms of Multiple Sclerosis (PMS) 4 2026-02-04
Atacicept in Multiple Glomerular Diseases Recruiting

2024-518465-10-00 Multiple Autoimmune Glomerular Diseases 4 2025-12-12
A Study to compare RLY-2608 + Fulvestrant with Capivasertib + Fulvestrant in people with PIK3CA-mutated, hormone-receptor positive, HER2-neg… Recruiting

2025-523083-21-00 PIK3CA-mutant Hormone Receptor Positive, Human Epiderma 5 2025-12-08
TRITON-CM: A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy Recruiting

2024-519917-72-00 Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amy 5 2025-10-29
Inhaled sedation in the critically ill patient Recruiting

2024-518521-14-00 Critical condition 6 2025-10-17
Pharmacokinetic Study of QL2107 Versus Keytruda® for Adjuvant Therapy of NSCLC Recruiting

2024-519883-42-00 Non-small cell lung cancer 5 2025-10-08
Dose Escalation and Dose Expansion Study of BBO-10203 in Subjects with Advanced Solid Tumors Recruiting

2024-519445-29-00 Solid Tumors 1 2025-10-02
Recombinant coagulation Factor VIIa administered at the earliest time for the treatment of stroke caused by bleeding in the brain - FASTEST… Recruiting

2024-517383-28-00 Acute haemorrhagic stroke 5 2025-07-21
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction Recruiting

2024-519219-32-00 Heart Failure With Reduced Ejection Fraction 5 2025-06-23
Safety, efficacy, and pharmacokinetics of BNT327 in combination with chemotherapy and other investigational agents for lung cancer Recruiting

2024-515764-31-00 Non-small cell lung cancer 10 2025-06-13
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of remibrutinib in patient… Recruiting

2023-510026-32-00 Generalized Myasthenia Gravis 5 2025-06-11
A clinical study to assess the safety and efficacy of oral ART0380 as a single agent or in combination in solid tumors Recruiting

2024-511534-12-00 Advanced or Metastatic Solid Tumours 7 2025-06-10
REscue of Nephrons with ALe.F02 (RENAL F02) Recruiting

2022-502184-38-00 Rapidly progressive glomerulonephritis 4 2025-06-06
Elacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast C… Recruiting

2024-515445-42-00 Node-positive, Estrogen Receptor-positive, HER2-negativ 5 2025-03-24
A global phase III study to investigate the effectiveness and safety of rilvegostomig plus chemotherapy to that of pembrolizumab plus chemot… Recruiting

2024-514281-39-00 Metastatic Squamous Non-small Cell Lung Cancer Whose Tu 5 2025-02-14
The role of intra-abdominal pressure and point of care ultrasound to guide decongestive therapy in Heart Failure (ABDOPOCUS-HF) Recruiting

2024-512901-22-00 Acute Heart Failure 5 2025-02-10
ZELA trial: Phase 2b/3 Multicenter Study to Evaluate the Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developi… Recruiting

2024-513420-41-00 prematurity in neonates 10 2025-01-09